Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Investing in Graphene Companies (Updated 2024)

Trending Press Releases

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

First Helium Reviewing Potential Follow Up Targets to Leduc Anomaly Drill

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

First Helium Initiates Process to License & Drill the Leduc Anomaly

SAGA Metals Announces Assay Results from North Wind Iron Ore Project

More Press Releases
Trending Companies

Silver47 Exploration

AGA:CC

Purpose Bitcoin ETF

BTCC:CA

Jindalee Lithium

JLL:AU

Fidelity Advantage Bitcoin ETF

FBTC:CC
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook

2024 AI Market Outlook Report

2024 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Aurinia Pharmaceuticals

NASDAQ:AUPH
Press Releases

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees

Aurinia Announces 2023 Annual General Meeting Results

Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021 the Company introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis LN. Aurinias head office is in Victoria British Columbia; its U.S. commercial hub is in Rockville Maryland; and the Company focuses development efforts globally. Follow us on Twitter at @AuriniaPharma and on LinkedIn.

Interactive Chart

×